Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1948 1
1949 2
1950 1
1952 2
1953 4
1954 6
1955 6
1956 3
1957 6
1958 4
1959 4
1960 7
1961 8
1962 9
1963 3
1964 6
1965 12
1966 9
1967 3
1968 2
1969 11
1970 9
1971 4
1972 6
1973 5
1974 5
1975 6
1976 5
1977 7
1978 6
1979 2
1980 4
1981 4
1982 5
1983 7
1984 4
1985 6
1986 5
1987 13
1988 9
1989 5
1990 20
1991 21
1992 17
1993 12
1994 22
1995 12
1996 19
1997 19
1998 15
1999 24
2000 25
2001 24
2002 34
2003 25
2004 32
2005 28
2006 32
2007 23
2008 31
2009 30
2010 19
2011 21
2012 19
2013 38
2014 21
2015 34
2016 35
2017 35
2018 44
2019 36
2020 41
2021 44
2022 50
2023 30
2024 43
2025 43
2026 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,174 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, Baron A, Park JW, Han G, Jassem J, Blanc JF, Vogel A, Komov D, Evans TRJ, Lopez C, Dutcus C, Guo M, Saito K, Kraljevic S, Tamai T, Ren M, Cheng AL. Kudo M, et al. Among authors: baron a. Lancet. 2018 Mar 24;391(10126):1163-1173. doi: 10.1016/S0140-6736(18)30207-1. Lancet. 2018. PMID: 29433850 Free article. Clinical Trial.
Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304).
Gutt CN, Encke J, Köninger J, Harnoss JC, Weigand K, Kipfmüller K, Schunter O, Götze T, Golling MT, Menges M, Klar E, Feilhauer K, Zoller WG, Ridwelski K, Ackmann S, Baron A, Schön MR, Seitz HK, Daniel D, Stremmel W, Büchler MW. Gutt CN, et al. Among authors: baron a. Ann Surg. 2013 Sep;258(3):385-93. doi: 10.1097/SLA.0b013e3182a1599b. Ann Surg. 2013. PMID: 24022431 Clinical Trial.
Parkinson's disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss.
Chemla A, Arena G, Sacripanti G, Barmpa K, Zagare A, Garcia P, Gorgogietas V, Antony P, Ohnmacht J, Baron A, Jung J, Lind-Holm Mogensen F, Michelucci A, Marzesco AM, Buttini M, Schmidt T, Grünewald A, Schwamborn JC, Krüger R, Saraiva C. Chemla A, et al. Among authors: baron a. Brain. 2025 Oct 3;148(10):3607-3622. doi: 10.1093/brain/awaf051. Brain. 2025. PMID: 39913247 Free PMC article.
Autoimmune swallowing disorders.
Amos J, Baron A, Rubin AD. Amos J, et al. Among authors: baron a. Curr Opin Otolaryngol Head Neck Surg. 2016 Dec;24(6):483-488. doi: 10.1097/MOO.0000000000000312. Curr Opin Otolaryngol Head Neck Surg. 2016. PMID: 27585081 Review.
Phase I Study of DSTP3086S, an Antibody-Drug Conjugate Targeting Six-Transmembrane Epithelial Antigen of Prostate 1, in Metastatic Castration-Resistant Prostate Cancer.
Danila DC, Szmulewitz RZ, Vaishampayan U, Higano CS, Baron AD, Gilbert HN, Brunstein F, Milojic-Blair M, Wang B, Kabbarah O, Mamounas M, Fine BM, Maslyar DJ, Ungewickell A, Scher HI. Danila DC, et al. Among authors: baron ad. J Clin Oncol. 2019 Dec 20;37(36):3518-3527. doi: 10.1200/JCO.19.00646. Epub 2019 Nov 5. J Clin Oncol. 2019. PMID: 31689155 Free PMC article. Clinical Trial.
Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational study.
Pogorelov D, Bode SFN, He X, Ramiro-Garcia J, Hedin F, Ammerlaan W, Konstantinou M, Capelle CM, Zeng N, Poli A, Domingues O, Montamat G, Hunewald O, Ciré S, Baron A, Longworth J, Demczuk A, Bazon ML, Casper I, Klimek L, Neuberger-Castillo L, Revets D, Guyonnet L, Delhalle S, Zimmer J, Benes V, Codreanu-Morel F, Lehners-Weber C, Weets I, Alper P, Brenner D, Gutermuth J, Guerin C, Morisset M, Hentges F, Schneider R, Shamji MH, Betsou F, Wilmes P, Glaab E, Cosma A, Goncalves J, Hefeng FQ, Ollert M. Pogorelov D, et al. Among authors: baron a. Nat Commun. 2024 Nov 26;15(1):10266. doi: 10.1038/s41467-024-54684-2. Nat Commun. 2024. PMID: 39592626 Free PMC article.
PARK7/DJ-1 promotes pyruvate dehydrogenase activity and maintains Treg homeostasis during ageing.
Danileviciute E, Zeng N, Capelle CM, Paczia N, Gillespie MA, Kurniawan H, Benzarti M, Merz MP, Coowar D, Fritah S, Vogt Weisenhorn DM, Gomez Giro G, Grusdat M, Baron A, Guerin C, Franchina DG, Léonard C, Domingues O, Delhalle S, Wurst W, Turner JD, Schwamborn JC, Meiser J, Krüger R, Ranish J, Brenner D, Linster CL, Balling R, Ollert M, Hefeng FQ. Danileviciute E, et al. Among authors: baron a. Nat Metab. 2022 May;4(5):589-607. doi: 10.1038/s42255-022-00576-y. Epub 2022 May 26. Nat Metab. 2022. PMID: 35618940
High-affinity agonists reveal recognition motifs for the MRGPRD GPCR.
Wang C, Liu Y, Lanier M, Yeager A, Singh I, Gumpper RH, Krumm BE, DeLeon C, Zhang S, Boehm M, Pittner R, Baron A, Dvorak L, Bacon C, Shoichet BK, Martinborough E, Fay JF, Cao C, Roth BL. Wang C, et al. Among authors: baron a. Cell Rep. 2024 Dec 24;43(12):114942. doi: 10.1016/j.celrep.2024.114942. Epub 2024 Nov 23. Cell Rep. 2024. PMID: 39580805 Free PMC article.
1,174 results